Wintrust Investments’s Ingredion INGR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
$60K Sell
442
-10
-2% -$1.41K 0.05% 230
2024
Q3
$62K Sell
452
-4,027
-90% -$512K 0.05% 284
2024
Q2
$514K Buy
4,479
+959
+27% +$111K 0.04% 282
2024
Q1
$411K Sell
3,520
-66
-2% -$7.43K 0.04% 314
2023
Q4
$389K Buy
3,586
+26
+0.7% +$2.61K 0.04% 313
2023
Q3
$350K Buy
3,560
+18
+0.5% +$1.87K 0.04% 310
2023
Q2
$375K Buy
3,542
+29
+0.8% +$3.08K 0.04% 299
2023
Q1
$357K Buy
3,513
+19
+0.5% +$1.9K 0.05% 244
2022
Q4
$342K Buy
3,494
+23
+0.7% +$2.12K 0.04% 268
2022
Q3
$279K Buy
+3,471
New +$305K 0.03% 316
2022
Q2
Sell
-2,709
Closed -$236K 398
2022
Q1
$236K Buy
2,709
+95
+4% +$8.6K 0.02% 362
2021
Q4
$253K Buy
2,614
+15
+0.6% +$1.44K 0.02% 368
2021
Q3
$231K Buy
+2,599
New +$229K 0.03% 248
2020
Q2
Sell
-2,784
Closed -$210K 363
2020
Q1
$210K Buy
2,784
+205
+8% +$17.6K 0.03% 295
2019
Q4
$240K Buy
+2,579
New +$217K 0.03% 315

Other funds holding INGR

Wintrust Investments's INGR Position: Q4 2024 in Review

Wintrust Investments reduced its Ingredion (INGR) stake by 2.2% in Q4 2024, selling an estimated $1.41K and leaving 442 shares worth $60K. The position accounts for 0.05% of the portfolio, ranked #230.

Wintrust Investments first reported a position in INGR in Q4 2019 and has held it in 15 quarters since. The position peaked at $514K in Q2 2024. 654 funds tracked by Wall St. Rank hold INGR as of Q4 2024.

  • Wintrust Investments held 442 shares of Ingredion worth $60K as of Q4 2024.
  • Wintrust Investments sold 10 Ingredion shares in Q4 2024, an estimated $1.41K.
  • Ingredion made up 0.05% of Wintrust Investments's portfolio in Q4 2024, its #230 holding.
  • Wintrust Investments first reported a position in Ingredion in Q4 2019 and has held it in 15 quarters since.
  • Wintrust Investments's Ingredion position peaked at $514K in Q2 2024.
  • 654 funds tracked by Wall St. Rank held Ingredion as of Q4 2024.

Based on Wintrust Investments's 13F filing for Q4 2024, filed 10 Feb 2025.